Clinical Trial

Multimodal Prehabilitation During Chemotherapy in Patients With Colorectal Liver Metastases

Study acronym: PREHABMET
Recruiting
View on ClinicalTrials.gov →
Summary
Liver resection is the only curative treatment for patients with colorectal liver metastases (CRLM). Most patients undergo chemotherapy (CT) before liver surgery. CT objectively decreases patient functional capacity. It has already been demonstrated that a structured training program carried out during the 4 weeks following CT, while the patient is waiting for liver resection, is able to return the functional capacity to baseline levels. Despite this, multimodal prehabilitation programs (MPP) during preoperative CT have not been evaluated or implemented. The aim of this study is to investigate whether a 16-week MPP applied during and following CT in CRLM patients will result in a significant increase in physical fitness when compared to those that undergo MPP only during the 4-weeks, between the end of CT and liver resection.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2020-08-18.
Status change: Not Yet Recruiting → Recruiting 2024-06-27
Trial Details
NCT Number NCT04520737
Lead Sponsor Institut Investigacio Sanitaria Pere Virgili
Conditions Prehabilitation, Neoadjuvant Therapy, Liver Metastases
Enrollment 84 participants
Start Date 2021-02-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-07-01